Part 2: Stem cells are potentially an endless source of healthy Retinal Pigment Epithelium (RPE) cells that may be used to replace damaged cells in macular degeneration.
Clinical trials for RPE replacement therapy for Stargardt's disease and dry AMD have begun. The study will assess the safety of replacing stem-cell derived RPE cells in humans.